Philip Lee
CEO
G
GeneFab
10/10Traction
GeneFab provides contract development and manufacturing services for cell and gene therapies, utilizing expertise in gene-to-cell design and optimization to enhance product manufacturability. The company addresses the challenges faced by innovators in bringing novel therapies to clinical application by offering flexible tech operations and transparent project management throughout the drug development lifecycle.
- Biotechnology
Updated 5 months ago
Funding
Funding not disclosed
ForwardassetNo round attributed
- forwardasset.com.tw (opens in a new tab)investor website
Funding rounds are not available yet.
Founders
Product
Problem
Developing and manufacturing cell and gene therapies is complex, often requiring specialized expertise in both gene design and scalable manufacturing processes. Innovators face challenges in optimizing product design for manufacturability and seamlessly integrating novel therapies with GMP platforms.
Solution
GeneFab offers contract research, development, and manufacturing services (CRDMO) focused on cell and gene therapies, providing expertise from gene-to-cell design through clinical manufacturing. The company emphasizes process and analytical development to ensure seamless integration of novel products with GMP platforms, minimizing time and risk. GeneFab's flexible tech operations teams and facilities are designed to rapidly respond to client needs and deliver on critical milestones. They also provide transparent project management, ensuring data and information are readily available to facilitate informed decision-making and project success.
Target Audience
GeneFab serves innovator companies developing cell and gene therapies, particularly those facing challenges in scaling production and navigating the complexities of GMP manufacturing.
Features
- Research expertise in gene-to-cell design and optimization to improve product design and manufacturability.
- Process & Analytical Development mindset for seamless integration of novel products with GMP platforms.
- Flexible Tech Ops teams and facilities to rapidly respond to client needs and deliver on critical milestones.
- Open project management style to ensure resources are aligned to support the drug development lifecycle.
- Detailed Project Gantt Charts and routine meeting structures.
- Collaborative knowledge and document sharing through secure, cloud-based tools.
- Rapid data sharing and routine monitoring/trending.
- Dedicated Program Management Officer to support communication channels, information flow, and technical collaboration.